GLOBAL TB REALITIES
TB is an airborne disease
4,000 people a day die from TB, 1.5 million a year
500,000 people today live with multi-drug resistant TB
TB is a leading killer among people living with HIV
TB is closely linked with social and economic marginalization
TB is mostly found in the "BRICS" countries, and in low-income settings
Q: Who is AA&D?
A. Advance Access & Delivery is a new initiative driving and supporting Zero TB Cities Project alongside key partners around the world. Read more here.
Q. Why cities?
A. Cities have their own resource base to fight the disease, strong institutions, and concentrated pockets of TB patients. Our work is centered on cities but is not exclusive to them, working toward elimination in any defined geographical area.
Q: Who funds AA&D?
A: We are funded by individuals, academic partnerships, foundations, multilaterals, and corporate support. Today, our initiative is housed within Partners In Health, 501(c)3, a leader in global health delivery, as fiscal agent.
Q: Where are your sites?
A: Our first two Zero TB Cities Project sites are in Chennai, India, and Lima, Peru. Both are among the largest cities on their respective continents and are tackling significant TB threats. New cities are working with us to consider launching in their
Building consensus for equitable care
From April 12 - April 16, 2015, more than 70 practitioners and policy experts in the area of TB care met for intensive practical sessions on treatment of latent TB infection, second-line drug supply chain innovations, and the Zero TB Cities Project.